Innate Pharma to participate in upcoming investor conferences

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members of its senior management team are scheduled to participate in the following upcoming conferences:  

  • American Society for Clinical Oncology (ASCO) 2023 Annual Meeting
  • Event Date: June 2-5, Chicago (USA)
  • Jefferies Healthcare Conference 2023
  • Event Date: June 7-9, New-York (USA)
  • Goldman Sachs 44th Annual Global Healthcare Conference
  • Event Date: June 12-15, Dana Point (USA)
  • Stifel European Healthcare Summit 2023
  • Event Date: June 28-30, Bordeaux (France)